Abstract
Expression of the gene encoding resistin, a low molecular weight protein secreted from adipose tissue postulated to link obesity and type II diabetes, was examined in 3T3-L1 adipocytes. Resistin mRNA was detected in 3T3-L1 cells by day 3 following induction of differentiation into adipocytes; by day 4 the level of resistin mRNA peaked and remained high. The PPARgamma activators, rosiglitazone or darglitazone, reduced the level of resistin mRNA. Dexamethasone upregulated resistin mRNA level, but no effect was observed with the beta(3)-adrenoceptor agonist, BRL 37344. A substantial reduction in resistin mRNA level was observed with insulin, which induced decreases at physiological concentrations. Insulin may be a major inhibitor of resistin production, and this does not support a role for resistin in insulin resistance.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
3T3 Cells
-
Adipocytes / cytology
-
Adipocytes / drug effects*
-
Adipocytes / metabolism*
-
Animals
-
Base Sequence
-
Cell Differentiation
-
DNA, Complementary / genetics
-
Gene Expression Regulation / drug effects
-
Hormones, Ectopic / genetics*
-
Humans
-
Insulin / pharmacology*
-
Insulin Resistance / physiology
-
Intercellular Signaling Peptides and Proteins*
-
Male
-
Mice
-
Mice, Inbred C57BL
-
Mice, Inbred CBA
-
Nerve Growth Factor
-
Oligodeoxyribonucleotides, Antisense / genetics
-
Proteins*
-
RNA, Messenger / genetics
-
RNA, Messenger / metabolism
-
Resistin
-
Tissue Distribution
Substances
-
DNA, Complementary
-
Hormones, Ectopic
-
Insulin
-
Intercellular Signaling Peptides and Proteins
-
Oligodeoxyribonucleotides, Antisense
-
Proteins
-
RETN protein, human
-
RETNLB protein, human
-
RNA, Messenger
-
Resistin
-
Retn protein, mouse
-
Retnla protein, mouse
-
Nerve Growth Factor